This remodeled AR signaling (ARS) and NE genes in the vicinity of chromatin, which in turn regulated the expression of ARS and NE genes and activated the AR signaling pathway, ultimately promoting the transformation of prostate cancer to NEPC (23). This evidence concerns the gene ELANE and prostate carcinoma.